stock listing Hong Kong Dx Firm Prenetics Shares Down 9 Percent on First Day on Nasdaq The company was valued at $1.25 billion with a combined equity value of $1.7 billion in September. AnPac Bio Receives Additional Nasdaq Warning Regarding Listing Requirement In January, the firm already received a notification from Nasdaq that it was not in compliance with the exchange's minimum market value of publicly held shares. AnPac Bio Warned by Nasdaq Over Listing Requirement The company has until July 18 to meet Nasdaq compliance by getting its market value of publicly held shares to at least $15 million. SomaLogic to List on Nasdaq Following SPAC Merger, Raises $630M Through the transaction, which values SomaLogic at roughly $1.2 billion, the company received gross cash proceeds of approximately $630 million. SomaLogic Reports Preliminary Q2 Revenues up 176 Percent The company projected Q2 revenues of $19.7 million and said the SEC had declared effective its proposed business combination with SPAC CM Life Sciences II. Feb 18, 2021 Protein Sequencing Firm Quantum-Si to Go Public Through Special Purpose Acquisition Company Merger Feb 8, 2021 Nautilus Biotechnology to Go Public on Nasdaq Through Merger With Special Purpose Acquisition Firm Jan 15, 2021 Bionano Genomics Stock Soars on User Presentations, Public Stock Offering, Renewed Nasdaq Compliance Jun 17, 2020 T2 Biosystems Regains Compliance With Nasdaq Listing Requirements Apr 27, 2020 Biocept Files $100M Shelf Registration May 3, 2019 Genetic Technologies Out of Compliance With Nasdaq Listing Rules Mar 22, 2018 Bio-Rad Receives Notice From NYSE for Late Filing of Annual Report Jan 9, 2018 Genetic Technologies Regains Compliance With Nasdaq Listing Rules Oct 18, 2017 Novacyt Raises €9.7M Aug 31, 2017 Interpace Regains Compliance With Nasdaq Listing Rule Jul 14, 2017 BGI Genomics Raises RMB 547M in IPO Jun 22, 2017 OpGen Warned by Nasdaq of Non-Compliance Apr 13, 2017 Interpace Diagnostics Regains Nasdaq Compliance Feb 21, 2017 Transgenomic Delisted from Nasdaq Jan 25, 2017 Biocept Regains Nasdaq Compliance Jan 17, 2017 Interpace Dx Regains Compliance With Nasdaq Listing Requirement Dec 15, 2016 WaferGen Regains Compliance With Nasdaq Listing Requirements Nov 28, 2016 Signal Genetics Regains Compliance With Nasdaq Listing Requirement Jul 11, 2016 Interpace Dx Gets Additional Time to Comply With Nasdaq Listing Requirements Jan 19, 2016 Toronto Stock Exchange Reviewing GeneNews' Eligibility for Continued Listing Load More Breaking News People in the News at Pacific Biosciences, Metabolon, NeoGenomics, More New Products Posted to GenomeWeb: Tethis, Invitae, PerkinElmer, More In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19 Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests Gene Expression, Histology Reveal Clues for Targeted Rheumatoid Arthritis Treatment The Scan Call for a Different Tack Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News. Wastewater Warning The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge. Can't Get in the Program Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports. Science Paper on Spatial-Controlled Genome Editing In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.